CLDX logo

Celldex Therapeutics, Inc. (CLDX) Selling, General & Administrative Expenses

Annual SG&A:

$38.55M+$7.63M(+24.69%)
December 31, 2024

Summary

  • As of today, CLDX annual SG&A is $38.55 million, with the most recent change of +$7.63 million (+24.69%) on December 31, 2024.
  • During the last 3 years, CLDX annual SG&A has risen by +$18.06 million (+88.15%).
  • CLDX annual SG&A is now at all-time high.

Performance

CLDX SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

Quarterly SG&A:

$10.39M-$429.00K(-3.96%)
June 30, 2025

Summary

  • As of today, CLDX quarterly SG&A is $10.39 million, with the most recent change of -$429.00 thousand (-3.96%) on June 30, 2025.
  • Over the past year, CLDX quarterly SG&A has increased by +$1.26 million (+13.84%).
  • CLDX quarterly SG&A is now -12.92% below its all-time high of $11.93 million, reached on December 31, 2016.

Performance

CLDX Quarterly SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

TTM SG&A:

-$6.34B-$199.61M(-3.25%)
June 30, 2025

Summary

  • As of today, CLDX TTM SG&A is -$6.34 billion, with the most recent change of -$199.61 million (-3.25%) on June 30, 2025.
  • Over the past year, CLDX TTM SG&A has dropped by -$6.37 billion (-18062.80%).
  • CLDX TTM SG&A is now -218451.59% below its all-time high of -$2.90 million.

Performance

CLDX TTM SG&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLDXincome statement metrics

Selling, General & Administrative Expenses Formula

SG&A = Total Operating Expenses - Cost of Goods Sold - Research & Development

CLDX Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+24.7%+13.8%-10000.0%
3Y3 Years+88.2%+45.3%-10000.0%
5Y5 Years+149.9%+194.5%-10000.0%

CLDX Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+88.2%-4.0%+59.1%-33.6%at low
5Y5-Yearat high+166.7%-4.0%+186.8%-53.6%at low
All-TimeAll-Timeat high+1928.8%-12.9%>+9999.0%>-9999.0%at low

CLDX Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$10.39M(-4.0%)
$41.53M(+3.1%)
Mar 2025
-
$10.82M(+5.4%)
$40.27M(+4.5%)
Dec 2024
$38.55M(+24.7%)
$10.26M(+2.1%)
$38.55M(+3.9%)
Sep 2024
-
$10.05M(+10.1%)
$37.12M(+5.2%)
Jun 2024
-
$9.13M(+0.3%)
$35.28M(+5.7%)
Mar 2024
-
$9.10M(+3.1%)
$33.38M(+8.0%)
Dec 2023
$30.91M(+13.7%)
$8.83M(+7.4%)
$30.91M(+7.8%)
Sep 2023
-
$8.22M(+13.8%)
$28.68M(+6.3%)
Jun 2023
-
$7.22M(+8.8%)
$26.99M(+0.2%)
Mar 2023
-
$6.64M(+0.6%)
$26.92M(-1.0%)
Dec 2022
$27.20M(+32.7%)
$6.60M(+1.0%)
$27.20M(+1.3%)
Sep 2022
-
$6.53M(-8.7%)
$26.84M(+2.7%)
Jun 2022
-
$7.15M(+3.5%)
$26.13M(+12.2%)
Mar 2022
-
$6.91M(+10.7%)
$23.28M(+13.6%)
Dec 2021
$20.49M(+41.7%)
$6.24M(+7.2%)
$20.49M(+14.6%)
Sep 2021
-
$5.82M(+35.2%)
$17.87M(+13.9%)
Jun 2021
-
$4.31M(+4.5%)
$15.69M(+5.2%)
Mar 2021
-
$4.12M(+13.7%)
$14.91M(+3.1%)
Dec 2020
$14.46M(-6.3%)
$3.62M(-0.5%)
$14.46M(+2.9%)
Sep 2020
-
$3.64M(+3.2%)
$14.05M(+1.7%)
Jun 2020
-
$3.53M(-3.8%)
$13.82M(-2.7%)
Mar 2020
-
$3.67M(+13.9%)
$14.20M(-8.0%)
Dec 2019
$15.43M(-19.9%)
$3.22M(-5.4%)
$15.43M(-6.7%)
Sep 2019
-
$3.40M(-12.9%)
$16.54M(-1.9%)
Jun 2019
-
$3.91M(-20.2%)
$16.86M(-9.2%)
Mar 2019
-
$4.90M(+13.0%)
$18.57M(-3.6%)
Dec 2018
$19.27M(-22.9%)
$4.33M(+16.4%)
$19.27M(-7.5%)
Sep 2018
-
$3.72M(-33.8%)
$20.83M(-7.2%)
Jun 2018
-
$5.62M(+0.5%)
$22.45M(-3.9%)
Mar 2018
-
$5.59M(-5.1%)
$23.37M(-6.5%)
Dec 2017
$25.00M(-30.5%)
$5.89M(+10.3%)
$25.00M(-19.5%)
Sep 2017
-
$5.35M(-18.2%)
$31.04M(-4.9%)
Jun 2017
-
$6.53M(-9.6%)
$32.65M(-3.7%)
Mar 2017
-
$7.23M(-39.4%)
$33.90M(-5.8%)
Dec 2016
$35.98M(+6.3%)
$11.93M(+71.7%)
$35.98M(+2.4%)
Sep 2016
-
$6.95M(-10.8%)
$35.12M(-4.2%)
Jun 2016
-
$7.79M(-16.3%)
$36.66M(-1.1%)
Mar 2016
-
$9.31M(-16.0%)
$37.05M(+9.5%)
Dec 2015
$33.84M(+64.1%)
$11.08M(+30.5%)
$33.84M(+16.6%)
Sep 2015
-
$8.49M(+3.7%)
$29.01M(+13.6%)
Jun 2015
-
$8.18M(+34.4%)
$25.53M(+15.4%)
Mar 2015
-
$6.09M(-2.6%)
$22.13M(+7.3%)
Dec 2014
$20.62M(+39.3%)
$6.25M(+24.9%)
$20.62M(+8.3%)
Sep 2014
-
$5.00M(+4.5%)
$19.05M(+8.1%)
Jun 2014
-
$4.79M(+4.5%)
$17.62M(+8.5%)
Mar 2014
-
$4.58M(-2.0%)
$16.25M(+9.8%)
Dec 2013
$14.80M(+47.8%)
$4.68M(+30.7%)
$14.80M(+15.9%)
Sep 2013
-
$3.58M(+4.9%)
$12.77M(+6.2%)
Jun 2013
-
$3.41M(+8.7%)
$12.03M(+11.0%)
Mar 2013
-
$3.14M(+18.7%)
$10.84M(+8.2%)
Dec 2012
$10.02M(+9.0%)
$2.64M(-6.7%)
$10.02M(+3.1%)
Sep 2012
-
$2.83M(+27.8%)
$9.71M(+6.1%)
Jun 2012
-
$2.22M(-4.2%)
$9.15M(-0.2%)
Mar 2012
-
$2.32M(-1.2%)
$9.17M(-0.7%)
Dec 2011
$9.19M(-11.4%)
$2.34M(+3.1%)
$9.24M(+3.3%)
Sep 2011
-
$2.27M(+1.5%)
$8.95M(+5.1%)
Jun 2011
-
$2.24M(-6.1%)
$8.52M(-4.0%)
Mar 2011
-
$2.39M(+16.4%)
$8.87M(-4.8%)
Dec 2010
$10.38M(-39.4%)
$2.05M(+11.3%)
$9.32M(-31.9%)
Sep 2010
-
$1.84M(-28.9%)
$13.69M(-12.8%)
Jun 2010
-
$2.59M(-8.6%)
$15.70M(-5.5%)
Mar 2010
-
$2.83M(-55.8%)
$16.61M(-3.0%)
Dec 2009
$17.12M(+16.1%)
$6.42M(+66.7%)
$17.12M(+60.0%)
Sep 2009
-
$3.85M(+9.7%)
$10.70M(-3.2%)
Jun 2009
-
$3.51M(+5.1%)
$11.06M(-9.0%)
Mar 2009
-
$3.34M(>+9900.0%)
$12.15M(+2.6%)
Dec 2008
$14.75M(+113.6%)
$0.00(-100.0%)
$11.84M(-38.7%)
Sep 2008
-
$4.21M(-8.7%)
$19.32M(+17.7%)
Jun 2008
-
$4.61M(+51.9%)
$16.42M(+27.6%)
Mar 2008
-
$3.03M(-59.5%)
$12.87M(+13.2%)
Dec 2007
$6.91M(-27.8%)
$7.48M(+472.7%)
$11.36M(+83.4%)
Sep 2007
-
$1.31M(+24.5%)
$6.20M(-7.6%)
Jun 2007
-
$1.05M(-31.3%)
$6.71M(-13.7%)
Mar 2007
-
$1.53M(-33.9%)
$7.78M(-5.6%)
DateAnnualQuarterlyTTM
Dec 2006
$9.56M(+38.7%)
$2.31M(+27.1%)
$8.24M(+8.7%)
Sep 2006
-
$1.82M(-14.1%)
$7.58M(+2.0%)
Jun 2006
-
$2.12M(+6.5%)
$7.43M(+3.6%)
Mar 2006
-
$1.99M(+20.3%)
$7.17M(+4.0%)
Dec 2005
$6.89M(+23.7%)
$1.65M(-1.0%)
$6.89M(-1.0%)
Sep 2005
-
$1.67M(-10.3%)
$6.96M(+5.8%)
Jun 2005
-
$1.86M(+8.8%)
$6.58M(+9.9%)
Mar 2005
-
$1.71M(-0.5%)
$5.99M(+7.5%)
Dec 2004
$5.57M(+4.1%)
$1.72M(+33.2%)
$5.57M(+7.1%)
Sep 2004
-
$1.29M(+1.6%)
$5.20M(-2.5%)
Jun 2004
-
$1.27M(-1.7%)
$5.34M(-1.5%)
Mar 2004
-
$1.29M(-4.3%)
$5.42M(+1.3%)
Dec 2003
$5.35M(-4.3%)
$1.35M(-5.1%)
$5.35M(-0.8%)
Sep 2003
-
$1.42M(+5.3%)
$5.39M(+1.9%)
Jun 2003
-
$1.35M(+10.4%)
$5.30M(-6.0%)
Mar 2003
-
$1.22M(-12.1%)
$5.63M(+0.7%)
Dec 2002
$5.59M(+13.8%)
$1.39M(+5.1%)
$5.59M(+2.3%)
Sep 2002
-
$1.33M(-21.4%)
$5.46M(+0.1%)
Jun 2002
-
$1.69M(+42.3%)
$5.46M(+10.1%)
Mar 2002
-
$1.19M(-6.3%)
$4.96M(-0.6%)
Dec 2001
$4.91M(+2.2%)
$1.27M(-4.3%)
$4.99M(-6.5%)
Sep 2001
-
$1.32M(+11.2%)
$5.34M(+5.4%)
Jun 2001
-
$1.19M(-2.1%)
$5.07M(+3.0%)
Mar 2001
-
$1.21M(-24.7%)
$4.92M(+2.3%)
Dec 2000
$4.81M(+12.3%)
$1.61M(+53.6%)
$4.81M(+50.5%)
Sep 2000
-
$1.05M(+0.8%)
$3.19M(+49.0%)
Jun 2000
-
$1.04M(-5.5%)
$2.14M(+94.5%)
Mar 2000
-
$1.10M(>+9900.0%)
$1.10M(>+9900.0%)
Dec 1999
$4.28M(+12.6%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$3.80M(+8.6%)
$0.00(0.0%)
$0.00(-100.0%)
Sep 1998
-
$0.00(0.0%)
$800.00K(-52.9%)
Jun 1998
-
$0.00(0.0%)
$1.70M(-39.3%)
Mar 1998
-
$0.00(-100.0%)
$2.80M(-22.2%)
Dec 1997
$3.50M(-46.2%)
$800.00K(-11.1%)
$3.60M(-14.3%)
Sep 1997
-
$900.00K(-18.2%)
$4.20M(0.0%)
Jun 1997
-
$1.10M(+37.5%)
$4.20M(-33.3%)
Mar 1997
-
$800.00K(-42.9%)
$6.30M(-3.1%)
Dec 1996
$6.50M(+10.2%)
$1.40M(+55.6%)
$6.50M(-3.0%)
Sep 1996
-
$900.00K(-71.9%)
$6.70M(-9.5%)
Jun 1996
-
$3.20M(+220.0%)
$7.40M(+34.5%)
Mar 1996
-
$1.00M(-37.5%)
$5.50M(-6.8%)
Dec 1995
$5.90M(+1.7%)
$1.60M(0.0%)
$5.90M(+5.4%)
Sep 1995
-
$1.60M(+23.1%)
$5.60M(+5.7%)
Jun 1995
-
$1.30M(-7.1%)
$5.30M(-7.0%)
Mar 1995
-
$1.40M(+7.7%)
$5.70M(-1.7%)
Dec 1994
$5.80M(-63.7%)
$1.30M(0.0%)
$5.80M(-30.1%)
Sep 1994
-
$1.30M(-23.5%)
$8.30M(-25.9%)
Jun 1994
-
$1.70M(+13.3%)
$11.20M(-17.6%)
Mar 1994
-
$1.50M(-60.5%)
$13.60M(-15.0%)
Dec 1993
$16.00M(+58.4%)
$3.80M(-9.5%)
$16.00M(+31.1%)
Sep 1993
-
$4.20M(+2.4%)
$12.20M(+2.5%)
Jun 1993
-
$4.10M(+5.1%)
$11.90M(+6.3%)
Mar 1993
-
$3.90M(0.0%)
$11.20M(-23.8%)
Dec 1992
$10.10M(-26.3%)
-
-
Oct 1992
-
$3.90M(+14.7%)
$14.70M(+4.3%)
Jul 1992
-
$3.40M(-12.8%)
$14.10M(+2.9%)
Apr 1992
-
$3.90M(+11.4%)
$13.70M(+5.4%)
Apr 1992
$13.70M(+6.2%)
-
-
Jan 1992
-
$3.50M(+6.1%)
$13.00M(+2.4%)
Oct 1991
-
$3.30M(+10.0%)
$12.70M(+0.8%)
Jul 1991
-
$3.00M(-6.3%)
$12.60M(-2.3%)
Apr 1991
$12.90M(+12.2%)
$3.20M(0.0%)
$12.90M(+1.6%)
Jan 1991
-
$3.20M(0.0%)
$12.70M(-0.8%)
Oct 1990
-
$3.20M(-3.0%)
$12.80M(+33.3%)
Jul 1990
-
$3.30M(+10.0%)
$9.60M(+52.4%)
Apr 1990
$11.50M(+38.6%)
$3.00M(-9.1%)
$6.30M(+90.9%)
Jan 1990
-
$3.30M
$3.30M
Apr 1989
$8.30M(+36.1%)
-
-
Apr 1988
$6.10M(+64.9%)
-
-
Apr 1987
$3.70M(+94.7%)
-
-
Apr 1986
$1.90M
-
-

FAQ

  • What is Celldex Therapeutics, Inc. annual SG&A?
  • What is the all-time high annual SG&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. annual SG&A year-on-year change?
  • What is Celldex Therapeutics, Inc. quarterly SG&A?
  • What is the all-time high quarterly SG&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. quarterly SG&A year-on-year change?
  • What is Celldex Therapeutics, Inc. TTM SG&A?
  • What is the all-time high TTM SG&A for Celldex Therapeutics, Inc.?
  • What is Celldex Therapeutics, Inc. TTM SG&A year-on-year change?

What is Celldex Therapeutics, Inc. annual SG&A?

The current annual SG&A of CLDX is $38.55M

What is the all-time high annual SG&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high annual SG&A is $38.55M

What is Celldex Therapeutics, Inc. annual SG&A year-on-year change?

Over the past year, CLDX annual SG&A has changed by +$7.63M (+24.69%)

What is Celldex Therapeutics, Inc. quarterly SG&A?

The current quarterly SG&A of CLDX is $10.39M

What is the all-time high quarterly SG&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high quarterly SG&A is $11.93M

What is Celldex Therapeutics, Inc. quarterly SG&A year-on-year change?

Over the past year, CLDX quarterly SG&A has changed by +$1.26M (+13.84%)

What is Celldex Therapeutics, Inc. TTM SG&A?

The current TTM SG&A of CLDX is -$6.34B

What is the all-time high TTM SG&A for Celldex Therapeutics, Inc.?

Celldex Therapeutics, Inc. all-time high TTM SG&A is -$2.90M

What is Celldex Therapeutics, Inc. TTM SG&A year-on-year change?

Over the past year, CLDX TTM SG&A has changed by -$6.37B (-18062.80%)
On this page